In results have shown that both PPARgamma agonist and antagonist produced the same results supporting the theory, that the blockade is indeed non PPARgamma-dependent. Moreover, the effect is AMPK-dependent as AMPK blocker attenuated both effect of PPARgamma agonist and antagonist on Beta-3-triggered lipolyses and NO production.